These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 6730014)
21. The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. Howat JM; Harris M; Swindell R; Barnes DM Br J Cancer; 1985 Feb; 51(2):263-70. PubMed ID: 3966982 [TBL] [Abstract][Full Text] [Related]
22. Prediction of relapse and survival in breast cancer patients by pS2 protein status. Foekens JA; Rio MC; Seguin P; van Putten WL; Fauque J; Nap M; Klijn JG; Chambon P Cancer Res; 1990 Jul; 50(13):3832-7. PubMed ID: 2354435 [TBL] [Abstract][Full Text] [Related]
23. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors. Macías A; Pascual MR; Pérez R; Lage A Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963 [TBL] [Abstract][Full Text] [Related]
24. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. Bardou VJ; Arpino G; Elledge RM; Osborne CK; Clark GM J Clin Oncol; 2003 May; 21(10):1973-9. PubMed ID: 12743151 [TBL] [Abstract][Full Text] [Related]
25. Clinical Characteristics and Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer in 2 Large Databases. Li Z; Tu Y; Wu Q; Wang Z; Li J; Zhang Y; Sun S Clin Breast Cancer; 2020 Apr; 20(2):e151-e163. PubMed ID: 31551181 [TBL] [Abstract][Full Text] [Related]
26. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors]. Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808 [TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor status as a prognostic indicator for stage I breast cancer patients. Crowe JP; Hubay CA; Pearson OH; Marshall JS; Rosenblatt J; Mansour EG; Hermann RE; Jones JC; Flynn WJ; McGuire WL Breast Cancer Res Treat; 1982; 2(2):171-6. PubMed ID: 7171837 [TBL] [Abstract][Full Text] [Related]
28. Estrogen & progesterone receptors measurement in breast cancer with enzyme-immunoassay & correlation with other prognostic factors. Redkar AA; Kabre SS; Mittra I Indian J Med Res; 1992 Feb; 96():1-8. PubMed ID: 1597324 [TBL] [Abstract][Full Text] [Related]
29. Progesterone and estrogen receptors as prognostic variables in breast cancer. Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609 [TBL] [Abstract][Full Text] [Related]
30. [Prognostic value of hormone receptor in breast cancer]. Yamamoto H; Morimoto T; Komaki K; Inui K; Ohshimo K; Tanaka T; Monden Y Nihon Geka Gakkai Zasshi; 1987 Jan; 88(1):96-101. PubMed ID: 3821719 [TBL] [Abstract][Full Text] [Related]
31. Steroid hormone receptors and prognosis in breast cancer. Daxenbichler G; Forsthuber EP; Marth C; Kemmler G; Wiegele J; Margreiter R; Müller L; Hausmaninger H; Manfreda D; Dapunt O Breast Cancer Res Treat; 1988 Dec; 12(3):267-73. PubMed ID: 3228589 [TBL] [Abstract][Full Text] [Related]
32. Oestrogen and progesterone receptor determinations in breast cancer: technology and biology. Thorpe SM; Rose C Cancer Surv; 1986; 5(3):505-25. PubMed ID: 3555780 [TBL] [Abstract][Full Text] [Related]
33. [Factors affecting estrogen and progesterone receptors in primary breast cancer]. Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431 [TBL] [Abstract][Full Text] [Related]
34. Receptor levels in breast cancer. Nardelli GB; Lamaina V; Marson S; Miola G Eur J Gynaecol Oncol; 1988; 9(1):54-8. PubMed ID: 3345786 [TBL] [Abstract][Full Text] [Related]
35. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer. Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243 [TBL] [Abstract][Full Text] [Related]
36. Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance. Thorpe SM Acta Oncol; 1988; 27(1):1-19. PubMed ID: 3284552 [TBL] [Abstract][Full Text] [Related]
37. The correlation between estrogen and progesterone receptors and some clinical and pathological features in human breast cancer. Caldarola L; Volterrani P; Lai M; Vigezzi P; Gaglia P Ital J Surg Sci; 1985; 15(4):329-33. PubMed ID: 3830952 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of estrogen and prolactin receptor analysis in human breast cancer. Waseda N; Kato Y; Imura H; Kurata M Jpn J Cancer Res; 1985 Jun; 76(6):517-23. PubMed ID: 2991064 [TBL] [Abstract][Full Text] [Related]
39. Concordance and discordance of estrogen and progesterone receptor content in sequential biopsies of patients with advanced breast cancer: relation to survival. Raemaekers JM; Beex LV; Koenders AJ; Pieters GF; Smals AG; Benraad TJ; Kloppenborg PW Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1011-8. PubMed ID: 6540683 [TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast. Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]